Medicamen Biotech Performance
- Today's Low
- ₹264
- Today's High
- ₹273
- 52 Week Low
- ₹217
- 52 Week High
- ₹449
- Open Price₹265
- Previous Close₹267
- Volume7,156
- 50 DMA₹275.15
- 100 DMA₹296.96
- 200 DMA₹332.21
Medicamen Biotech Chart
Investment Returns
- Over 1 Month + 3.88%
- Over 3 Month -10.83%
- Over 6 Month -32.75%
- Over 1 Year -37.25%
Smart Investing Starts Here Start SIP with Medicamen Biotech for Steady Growth!
Medicamen Biotech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 38.8
- PEG Ratio
- 1.9
- Market Cap Cr
- 366
- P/B Ratio
- 1.3
- Average True Range
- 13.8
- EPS
- 6.94
- Dividend Yield
- 0.4
- MACD Signal
- 3.62
- RSI
- 49.83
- MFI
- 48.46
Latest Stock News Updates
Medicamen Biotech stock rose following the announcement of a strategic partnership with XGX Pharma, a European company.
- Business Standard
- 1 year 1 month ago
Medicamen Biotech filed its first Abbreviated New Drug Application in eCTD format for BORTEZOMIB FOR injection 3.5 MG/VIAL' with the US Food and Drug Administration
- Business Line
- 2 years 10 months ago
Medicamen Biotech Financials
Medicamen Biotech Technicals
EMA & SMA
- Bearish Moving Average 14
- Bullish Moving Average 2
- 20 Day
- ₹270.61
- 50 Day
- ₹275.15
- 100 Day
- ₹296.96
- 200 Day
- ₹332.21
Resistance and Support
- R3 283.17
- R2 278.28
- R1 273.92
- S1 264.67
- S2 259.78
- S3 255.42
Medicamen Biotech Corporate Actions - Bonus, Splits, Dividends
About Medicamen Biotech
- NSE Symbol
- MEDICAMEQ
- BSE Symbol
- 531146
- ISIN
- INE646B01010
Similar Stocks to Medicamen Biotech
Popular Stocks
Medicamen Biotech FAQs
Medicamen Biotech share price is ₹269 As on 24 May, 2026 | 21:58
The Market Cap of Medicamen Biotech is ₹365.6 Cr As on 24 May, 2026 | 21:58
The P/E ratio of Medicamen Biotech is 38.8 As on 24 May, 2026 | 21:58
The PB ratio of Medicamen Biotech is 1.3 As on 24 May, 2026 | 21:58
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.